Cargando…

Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study

The current study examined risk factors for sporadic pancreatic neuroendocrine tumors (PNETs), including smoking, alcohol use, first-degree family history of any cancer (FHC), and diabetes in the Han Chinese ethnic group. In this clinic-based case-control analysis on 385 patients with sporadic PNETs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben, Qiwen, Zhong, Jie, Fei, Jian, Chen, Haitao, Yv, Lifen, Tan, Jihong, Yuan, Yaozong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080551/ https://www.ncbi.nlm.nih.gov/pubmed/27782199 http://dx.doi.org/10.1038/srep36073

Ejemplares similares

Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population
por: Ben, Qiwen, et al.
Publicado: (2017)

Association Between Consumption of Fruits and Vegetables and Risk of Colorectal Adenoma: A PRISMA-Compliant Meta-Analysis of Observational Studies
por: Ben, Qiwen, et al.
Publicado: (2015)

Surgical Treatment of Sporadic Pancreatic Neuroendocrine Tumors: A State of the Art Review
por: Haugvik, Sven-Petter, et al.
Publicado: (2012)

Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitro
por: BEN, QIWEN, et al.
Publicado: (2014)

Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
por: Mei, Wentong, et al.
Publicado: (2023)

Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
por: Wang, Zhe, et al.
Publicado: (2020)

Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing
por: Zheng, Kailian, et al.
Publicado: (2021)

A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
por: Soczomski, Przemysław, et al.
Publicado: (2021)

Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
por: Chen, Hong-Yu, et al.
Publicado: (2020)

Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study
por: Zhang, Pan, et al.
Publicado: (2019)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Ben, Qiwen, et al.
Publicado: (2020)

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine
por: Simbolo, Michele, et al.
Publicado: (2018)

Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases
por: Guo, Yiying, et al.
Publicado: (2023)

Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors
por: Molasy, Bartosz, et al.
Publicado: (2022)

Diagnosis of Pancreatic Neuroendocrine Tumors
por: Lee, Dong Wook, et al.
Publicado: (2017)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
por: Abbasi, Arezou, et al.
Publicado: (2020)

Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms
por: HAUGVIK, SVEN-PETTER, et al.
Publicado: (2014)

MON-903 Sporadic Phaeochromocytoma, Pancreatic Neuroendocrine Tumour and a Sacral Hibernoma: A Case Report
por: Pandher, Ravind Singh, et al.
Publicado: (2020)

The Impact of (68)Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis
por: He, Chao-bin, et al.
Publicado: (2019)

Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review
por: Chen, Jeffrey W., et al.
Publicado: (2023)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors
por: Song, Yu-Li, et al.
Publicado: (2017)

Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group
por: Ptasnuka, Margarita, et al.
Publicado: (2023)

Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
por: Feng, Tingting, et al.
Publicado: (2019)

Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020)

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022)

CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
por: Zhong, Yanqi, et al.
Publicado: (2023)

Neuroendocrine Differentiation in Sporadic CRC and Hereditary Nonpolyosis Colorectal Cancer
por: Sun, M. H.
Publicado: (2004)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Prognostic Factors and Characteristics of Pancreatic Neuroendocrine Tumors: Single Center Experience
por: Oh, Tak Geun, et al.
Publicado: (2012)

Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
por: Takeda, Yasutaka, et al.
Publicado: (2017)

Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors
por: Shi, Min, et al.
Publicado: (2021)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations
por: Xu, Midie, et al.
Publicado: (2022)

Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study
por: Tan, Qingquan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_al62gju6k07eh3lav1hg647qt2